Nevanimibe (ATR-101)
目录号: A14395
ACAT1 抑制剂
ATR-101 正在临床开发中,用于治疗肾上腺皮质癌(ACC)。
Discription | ATR-101 is in clinical development for the treatment of adrenocortical carcinoma (ACC). | ||
---|---|---|---|
Targets |
|
目录号 | A14395 |
---|---|
分子式 | C28H41N3O |
分子量 | 435.64 |
CAS号 | 133825-80-6 |
SMILES | CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)NCC2(CCCC2)C3=CC=C(C=C3)CN(C)C |
其他名称 | ATR 101, ATR101, PD-132301 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2